Company Filing History:
Years Active: 2020-2022
Title: The Innovative Contributions of Alessandro Pace
Introduction
Alessandro Pace is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel drug formulations. With a total of two patents to his name, his work focuses on improving treatment options for serious medical conditions.
Latest Patents
Pace's latest invention is the cyclodextrin-panobinostat adduct. This innovative method involves producing a cyclodextrin-panobinostat adduct through a series of steps. First, a first aqueous solution containing a buffering agent is prepared, maintaining a pH between 2.0 and 4.0. Next, panobinostat is dissolved in this solution to create a second aqueous solution. Finally, this second solution is mixed with a third aqueous solution containing cyclodextrin, resulting in a fourth aqueous solution that comprises the cyclodextrin-panobinostat adduct. This invention also includes an artificial cerebrospinal fluid (CSF) solution that incorporates the cyclodextrin-panobinostat adduct, which has potential medical applications, including the treatment of brain tumors.
Career Highlights
Throughout his career, Alessandro Pace has worked with various companies, including Midatech Limited and Midatech Pharma Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Pace has collaborated with notable colleagues such as Tom Coulter and Stephen Damment. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Alessandro Pace's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving medical treatments. His work, particularly in developing the cyclodextrin-panobinostat adduct, showcases the potential for advancements in the treatment of serious health conditions.